Significance of immunohistochemical c-erbB-2 product localization pattern for prognosis of primary human breast cancer

This publication has 10 references indexed in Scilit:

• An activated allele of the c-erbB-2 oncogene impairs kidney and lung function and causes early death of transgenic mice
  Journal of Cell Biology, 1993
• Hormonal regulation of c-erbB-2 oncogene expression in breast cancer cells
  The Journal of Steroid Biochemistry and Molecular Biology, 1992
• Correlation of HER-2/neu Amplification With Expression and With Other Prognostic Factors in 1103 Breast Cancers
  JNCI: Journal of the National Cancer Institute, 1992
• c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma.
  Journal of Clinical Pathology, 1992
• Estrogen suppression of erbB2 expression is associated with increased growth rate of ZR‐75‐1 human breast cancer cells in vitro and in nude mice
  International Journal of Cancer, 1991
• c-erbB-2 oncogene as a prognostic marker in breast cancer
  British Journal of Cancer, 1991
• c-erbB-2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes
  British Journal of Cancer, 1991
• c‐erbB‐2 proto‐oncogene product
  Histopathology, 1990
• Differentiation of cultured human breast cancer cells (AU‐565 and MCF‐7) associated with loss of cell surface HER‐2/neu antigen
  Molecular Carcinogenesis, 1990
• Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu Oncogene
  Science, 1985